Quick10K

⚲

Resolute Energy

Filings

10-Q	2018-09-30	Filed 2018-11-05
10-Q	2018-06-30	Filed 2018-08-06
10-Q	2018-03-31	Filed 2018-05-07
10-K	2017-12-31	Filed 2018-03-12
10-Q	2017-09-30	Filed 2017-11-06
10-Q	2017-06-30	Filed 2017-08-07
10-Q	2017-03-31	Filed 2017-05-03
10-K	2016-12-31	Filed 2017-03-13
10-Q	2016-09-30	Filed 2016-11-07
10-Q	2016-06-30	Filed 2016-08-08
10-Q	2016-03-31	Filed 2016-05-09
10-K	2015-12-31	Filed 2016-03-07
10-Q	2015-09-30	Filed 2015-11-09
10-Q	2015-06-30	Filed 2015-08-10
10-Q	2015-03-31	Filed 2015-05-11
10-K	2014-12-31	Filed 2015-03-05
10-Q	2014-09-30	Filed 2014-11-10
10-Q	2014-06-30	Filed 2014-08-11
10-Q	2014-03-31	Filed 2014-05-12
10-K	2013-12-31	Filed 2014-03-10
10-Q	2013-09-30	Filed 2013-11-05
10-Q	2013-06-30	Filed 2013-08-05
10-Q	2013-03-31	Filed 2013-05-06
10-Q	2012-06-30	Filed 2012-08-06
10-Q	2012-03-31	Filed 2012-05-08
10-Q	2011-09-30	Filed 2011-11-07
10-Q	2011-06-30	Filed 2011-08-08
10-Q	2011-03-31	Filed 2011-05-06
10-K	2010-12-31	Filed 2011-03-15
10-Q	2010-09-30	Filed 2010-11-15
10-Q	2010-06-30	Filed 2010-08-12
10-Q	2010-03-31	Filed 2010-05-11
10-K	2009-12-31	Filed 2010-03-30

Reports

8-K	2019-03-01
8-K	2019-02-22
8-K	2019-02-14
8-K	2019-02-11
8-K	2018-11-19
8-K	2018-11-18
8-K	2018-10-11
8-K	2018-09-30
8-K	2018-09-14
8-K	2018-06-30
8-K	2018-06-19
8-K	2018-06-11
8-K	2018-05-15
8-K	2018-05-09
8-K	2018-04-05
8-K	2018-03-31
8-K	2018-03-16
8-K	2018-03-12
8-K	2018-02-26
8-K	2018-02-13
8-K	2018-02-08
8-K	2018-01-01

Resolute Energy Financials

REN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30
Cash	0	0	1	1	3	2	18	2	1	1	18	1	1	1	20	1	0	1	22	3	0	1	133	1	1	1	23	1	1	3
Accounts Receivable	51	55	62	70	74	76	78	91	92	96	94	67	66	69	58	45	43	38	37	35	43	47	55	51	73	74	63	59	61	66
Inventory
PP&E	717	801	840	871	944	937	1,231	1,454	1,488	1,474	1,333	1,338	1,354	1,368	1,243	1,018	748	537	223	185	209	198	373	391	620	691	554	603	730	802
Assets	809	895	948	993	1,073	1,066	1,364	1,601	1,631	1,615	1,469	1,446	1,466	1,477	1,455	1,228	911	729	391	322	318	295	588	490	729	792	642	686	827	898
Accounts Payable											33	20	20	20	26	16	8	7	7	13	16	8	9	18	24	27	16	26	30	25
Long-Term Debt	66	146	170	188	27	18	564	792	722	687	737	722	737	737	776	768	735	716	513	514	545	517	538	419	625	650	555	565	673	710
Liabilities	318	365	432	476	540	533	832	1,069	984	968	935	914	946	938	928	907	846	843	594	608	639	634	664	565	791	866	716	768	909	993
Stockholders' Equity	491	531	516	517	532	532	532	532	647	648	534	531	520	539	527	321	65	-115	-203	-286	-322	-339	-76	-76	-62	-74	-74	-82	-83	-95


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30
Revenue	60	54	59	64	74	63	67	79	105	89	93	91	90		66				28									75	73	107
Cost of Revenue
Gross Profit
R&D
SG&A	5	5	6	5	6	7	6	9	9	9	9	9	10	10	11	7	8	7	9	9	8	7	9	10	9	10	19	21	16	10
Tax	15	23	-10	-0	14	-2	0	-2	5	-2	-67	-1	-6	7	-4	-22	-30	0	0					0	0	-0	-0	0	0	0
Net Income	26	38	-16	-1	23	-2	-2	-3	9	-3	-117	-4	-16	15	-17	-208	-259	-183	-92	-85	-37	-19	-21	1	13	-15	-1	-13	-4	-14


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30
Cash Operating		19	32	29	12	27	9	28	36	46	22	63	29	37	15	31	10	31	-2	17	7	35	25	39	13	60	25	46		78
Cash Investing		-98	-55	-47	-80	-18	-302	-254	-68	-11	-72	-45	-44	-38	-49	-35	24	-9	220	-23	-39	-5	-123	-45	-217	-83	74	-56		-111
Cash Financing		79	23	18	70	-9	291	226	31	-35	49	-16	15	-0	38	1	-34	-21	-210	-0	30	-30	231	-126	204	23	-96	7		35